D-0143-2020 Class II Terminated
FDA drug recall D-0143-2020 was initiated by Aurobindo Pharma USA Inc. on Sep 19, 2019 and is designated Class II. Reason for recall: Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness. The recall status is terminated (terminated Apr 4, 2023). Affected quantity: 11,129 100-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 23, 2019
- Initiation Date
- Sep 19, 2019
- Termination Date
- Apr 4, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,129 100-count bottles
Product description
Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01
Reason for recall
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Distribution pattern
Nationwide in the US
Code information
Batch 07319032A1, Exp 02/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0143-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026